Endo Pharma, Bioniche to present Urocidin Phase III trial results
Urocidin is a formulation of MCC, a sterile mycobacterial cell wall-DNA complex composition that acts dually to stimulate immunity as well as exert direct anticancer activity, and is
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.